BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Eurand to Participate in Upcoming Investor Conferences


11/2/2010 9:26:35 AM

YARDLEY, PA--(Marketwire - November 01, 2010) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate in the following upcoming investor conferences:

Event:
2010 Credit Suisse Healthcare Conference
Date:
Friday, November 12, 2010
Time:
8:00 a.m. MT (Presentation by Eurand Chief Commercial Officer John Fraher)
Place:
Arizona Biltmore
2400 East Missouri Avenue
Phoenix, Ariz.

Event:
Barclays Capital Healthcare Small- and Mid-Cap One-on-One Day
Date:
Thursday, November 18, 2010
Time:
8:00 a.m. to 5:00 p.m. CT (Individual Meetings -- Time is Approximate)
Place:
Graves 601 Hotel
601 First Avenue North
Minneapolis, Minn.

An audio webcast of the Company's presentation at the Credit Suisse Conference will be available by accessing the investor relations section of www.eurand.com and will be available via replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved
by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.


Contacts:
Bill Newbould
Vice President, Investor Relations
Eurand N.V.
+1-267-759-9335
Email Contact

Nick Laudico/Sara Pellegrino
The Ruth Group
+1-646-536-7030/7002
Email Contact
Email Contact



Read at BioSpace.com

Eurand
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES